Concepedia

Huanyu Chen

HC

Statistics

Publications

33

Citations

2.5K

H-Index

23

Active since

2006

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Peking University Cancer Hospital

Peking University

Anyang Tumor Hospital

Huanyu Chen is an author at Center for Drug Evaluation and Research specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2006–2024

33

Publications

33

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Zev A. Wainberg, Davide Melisi, Teresa Macarulla et al. · The Lancet · 2023 · 374 citations · Full text

FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements

Dickran Kazandjian, Gideon M. Blumenthal, Huanyu Chen et al. · The Oncologist · 2014 · 283 citations · Full text

Associations of Increases in Serum Creatinine with Mortality and Length of Hospital Stay after Coronary Angiography

Steven D. Weisbord, Huanyu Chen, Roslyn A. Stone et al. · Journal of the American Society of Nephrology · 2006 · 228 citations

, , +21

FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1

Lola A. Fashoyin‐Aje, Martha Donoghue, Huanyu Chen et al. · The Oncologist · 2018 · 224 citations · Full text

Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis

Julia A. Beaver, Maitreyee Hazarika, Flora Mulkey et al. · The Lancet Oncology · 2018 · 172 citations · Full text

, , +10

1–5 of 33